None
Conditions
Interventions
Newer and ordinary fine needle blood sampling
Sponsors
Keio university school of medicine, division of rheumatology
DNA CHIP Research Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy volunteer
Exclusion criteria
Exclusion criteria: persons who did not acceptable for informed concent and inadequate for this the trial by doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison safety (VAS of Pain and general) and Efficacy (sampling time, amount and quality of RNA / DNA and protein assay etc.) between blood sampling using nobel extrafine needle and that in coventional method. | — |
Countries
Japan
Contacts
Public ContactKatsuya Suzuki
Keio university school of medicine Division of Rheumatology
Outcome results
None listed